(Q37139335)

18 August 2017

The use of budesonide in the treatment of autoimmune hepatitis in Canada (English)

1 reference

18 August 2017

0 references

1 reference

Iman Zandieh

1

1 reference

18 August 2017

Darin Krygier

2

1 reference

18 August 2017

Victor Wong

3

1 reference

18 August 2017

John Howard

4

1 reference

18 August 2017

Lawrence Worobetz

5

1 reference

18 August 2017

Gerald Minuk

6

1 reference

18 August 2017

Helga Witt-Sullivan

7

1 reference

18 August 2017

Eric M Yoshida

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

Canadian Journal of Gastroenterology

18 August 2017

0 references

volume

22

1 reference

18 August 2017

4

1 reference

18 August 2017

388-392

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

18 August 2017

start time

1 January 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Budesonide induces complete remission in autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Autoantibodies and autoantigens in autoimmune hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Prevalence and epidemiology of autoimmune hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Current and novel immunosuppressive therapy for autoimmune hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Recurrence of autoimmune hepatitis after liver transplantation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Oral budesonide for treatment of autoimmune chronic active hepatitis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

D-penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effects.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Budesonide in previously untreated autoimmune hepatitis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Diagnosis and treatment of autoimmune hepatitis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662897

Controlled trial of prednisone and azathioprine in active chronic hepatitis

3 September 2018

1 reference

12 December 2020

Azathioprine for long-term maintenance of remission in autoimmune hepatitis

1 reference

12 December 2020

Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

1 reference

12 December 2020

Oral budesonide therapy for steroid-dependent ulcerative colitis: a pilot trial

1 reference

12 December 2020

Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate

1 reference

12 December 2020

Follow-up of children with autoimmune hepatitis treated with cyclosporine

1 reference

12 December 2020

Failure of customary treatment in chronic active liver disease: causes and management

1 reference

12 December 2020

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial

1 reference

12 December 2020

Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis

1 reference

12 December 2020

Duration of immunosuppressive therapy in autoimmune hepatitis

1 reference

12 December 2020

Methotrexate therapy for refractory chronic active autoimmune hepatitis

1 reference

12 December 2020

Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival

1 reference

12 December 2020

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

1 reference

12 December 2020

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis

1 reference

12 December 2020

Meeting report: International Autoimmune Hepatitis Group

1 reference

12 December 2020

A comparison of budesonide with prednisolone for active Crohn's disease

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/xmpsweciv5ebjgk2bwpsrwpvsu

Identifiers

1 reference

30 July 2022

release_xmpsweciv5ebjgk2bwpsrwpvsu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xmpsweciv5ebjgk2bwpsrwpvsu

30 July 2022

https://api.fatcat.wiki/v0/release/xmpsweciv5ebjgk2bwpsrwpvsu

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/xmpsweciv5ebjgk2bwpsrwpvsu

PubMed publication ID

1 reference

30 July 2022